chrX-47846275-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_007137.5(ZNF81):​c.8C>T​(p.Ala3Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0161 in 1,207,460 control chromosomes in the GnomAD database, including 136 homozygotes. There are 6,115 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.012 ( 13 hom., 344 hem., cov: 23)
Exomes 𝑓: 0.017 ( 123 hom. 5771 hem. )

Consequence

ZNF81
NM_007137.5 missense

Scores

3
13

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.245

Publications

7 publications found
Variant links:
Genes affected
ZNF81 (HGNC:13156): (zinc finger protein 81) This gene encodes a protein that likely functions as a transcription factor. The protein contains an N-terminal KRAB domain and several C2H2-type zinc finger motifs. Mutations in this gene cause an X-linked form of intellectual disability (MRX45). Microduplication of a region of chromosome X including this gene has also been associated with other forms of intellectual disability. [provided by RefSeq, Jul 2017]
ZNF81 Gene-Disease associations (from GenCC):
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • intellectual disability, X-linked 45
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
  • X-linked intellectual disability
    Inheritance: XL Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0035823584).
BP6
Variant X-47846275-C-T is Benign according to our data. Variant chrX-47846275-C-T is described in ClinVar as Benign. ClinVar VariationId is 130859.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0117 (1309/112342) while in subpopulation NFE AF = 0.0187 (997/53230). AF 95% confidence interval is 0.0178. There are 13 homozygotes in GnomAd4. There are 344 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 13 Unknown,XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ZNF81NM_007137.5 linkc.8C>T p.Ala3Val missense_variant Exon 2 of 5 ENST00000338637.13 NP_009068.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ZNF81ENST00000338637.13 linkc.8C>T p.Ala3Val missense_variant Exon 2 of 5 3 NM_007137.5 ENSP00000341151.7

Frequencies

GnomAD3 genomes
AF:
0.0117
AC:
1313
AN:
112290
Hom.:
14
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00305
Gnomad AMI
AF:
0.0425
Gnomad AMR
AF:
0.0124
Gnomad ASJ
AF:
0.00604
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00110
Gnomad FIN
AF:
0.00323
Gnomad MID
AF:
0.0210
Gnomad NFE
AF:
0.0187
Gnomad OTH
AF:
0.0112
GnomAD2 exomes
AF:
0.00925
AC:
1607
AN:
173816
AF XY:
0.00854
show subpopulations
Gnomad AFR exome
AF:
0.00286
Gnomad AMR exome
AF:
0.00574
Gnomad ASJ exome
AF:
0.00589
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00294
Gnomad NFE exome
AF:
0.0163
Gnomad OTH exome
AF:
0.0103
GnomAD4 exome
AF:
0.0166
AC:
18178
AN:
1095118
Hom.:
123
Cov.:
30
AF XY:
0.0160
AC XY:
5771
AN XY:
361160
show subpopulations
African (AFR)
AF:
0.00239
AC:
63
AN:
26363
American (AMR)
AF:
0.00614
AC:
215
AN:
34996
Ashkenazi Jewish (ASJ)
AF:
0.00574
AC:
111
AN:
19324
East Asian (EAS)
AF:
0.0000332
AC:
1
AN:
30163
South Asian (SAS)
AF:
0.00158
AC:
84
AN:
53328
European-Finnish (FIN)
AF:
0.00343
AC:
138
AN:
40250
Middle Eastern (MID)
AF:
0.00318
AC:
11
AN:
3454
European-Non Finnish (NFE)
AF:
0.0201
AC:
16923
AN:
841296
Other (OTH)
AF:
0.0138
AC:
632
AN:
45944
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.456
Heterozygous variant carriers
0
688
1377
2065
2754
3442
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
636
1272
1908
2544
3180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0117
AC:
1309
AN:
112342
Hom.:
13
Cov.:
23
AF XY:
0.00997
AC XY:
344
AN XY:
34502
show subpopulations
African (AFR)
AF:
0.00304
AC:
94
AN:
30924
American (AMR)
AF:
0.0124
AC:
132
AN:
10630
Ashkenazi Jewish (ASJ)
AF:
0.00604
AC:
16
AN:
2647
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3571
South Asian (SAS)
AF:
0.00110
AC:
3
AN:
2716
European-Finnish (FIN)
AF:
0.00323
AC:
20
AN:
6193
Middle Eastern (MID)
AF:
0.00461
AC:
1
AN:
217
European-Non Finnish (NFE)
AF:
0.0187
AC:
997
AN:
53230
Other (OTH)
AF:
0.0111
AC:
17
AN:
1532
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
56
112
168
224
280
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0144
Hom.:
654
Bravo
AF:
0.0120
TwinsUK
AF:
0.0183
AC:
68
ALSPAC
AF:
0.0208
AC:
60
ESP6500AA
AF:
0.00260
AC:
9
ESP6500EA
AF:
0.0200
AC:
130
ExAC
AF:
0.00894
AC:
1081

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Dec 27, 2012
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

History of neurodevelopmental disorder Benign:1
Nov 20, 2012
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.16
BayesDel_addAF
Benign
-0.69
T
BayesDel_noAF
Benign
-0.74
CADD
Benign
16
DANN
Uncertain
1.0
DEOGEN2
Benign
0.043
T;T;.;.
FATHMM_MKL
Benign
0.083
N
LIST_S2
Benign
0.52
.;T;T;T
MetaRNN
Benign
0.0036
T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.7
L;L;.;.
PhyloP100
0.24
PrimateAI
Benign
0.35
T
PROVEAN
Benign
-0.030
N;N;N;N
REVEL
Benign
0.027
Sift
Uncertain
0.0060
D;D;T;T
Sift4G
Uncertain
0.036
D;D;T;T
Polyphen
0.32
B;B;.;.
Vest4
0.073
MVP
0.44
MPC
0.15
ClinPred
0.0037
T
GERP RS
2.7
Varity_R
0.11
gMVP
0.15
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs183846665; hg19: chrX-47705674; COSMIC: COSV99061323; COSMIC: COSV99061323; API